Author

Pui-Kai Li

The Ohio State University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

Shabber MohammediD· 2 shared Aiden Tamulonis· 1 shared Ann Ventura· 1 shared Anuvrat Sarkar· 1 shared David R. ShermaniD· 1 shared Dharani Mayilsamy· 1 shared Enming XingiD· 1 shared Hassan E. EldesoukyiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMolecular Biology

Shabber MohammedORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Design, Amino-Acid-Derived Analogues of FTY-720 and OSU-2S as PP2A Activators: Structure-Activity Relationships and Identification of Lead Compound XML-3D

Rui Yang, Noura Srour, Pankajavalli Thirugnanasambandam, Shabber Mohammed, Megan E. Roderick, Santhanam Ramasamy, Ann Ventura, Enming Xing, Jeffrey Cheng, Xiaolin Cheng, Aiden Tamulonis, Dharani Mayilsamy, Anuvrat Sarkar, Lalit Sehgal, Natarajan Muthusamy, Pui-Kai Li

The paper designs and evaluates amino-acid-derived PP2A activators, identifies XML-3D as a lead compound with improved cytotoxicity compared to FTY-720 and OSU-2S.

bioRxiv · Oct 14, 2026 · PreprintMolecular Biology

Netupitant Exhibits Potent Activity on Mycobacterium tuberculosis Persisters

Hassan E. Eldesouky, Richard M. Jones, Natalie Gleason, Shabber Mohammed, 邢恩明, Pui-Kai Li, David R. Sherman

This study identifies netupitant as a compound that enhances anti-TB drug activity and eliminates Mtb persisters, showing potent bacteriostatic and tuberculocidal effects in combination with standard drugs.

ACS Infectious Diseases · Jul 18, 2025Peer-reviewedMicrobiology